Irritable Bowel Syndrome Therapy
Active substance: ASAFETIDA, BISMUTH SUBNITRATE, BRYONIA ALBA ROOT, ACTIVATED CHARCOAL, LYCOPODIUM CLAVATUM SPORE, SODIUM CARBONATE, STRYCHNOS NUX-VOMICA SEED, VERATRUM ALBUM ROOT
TABLET, ORALLY DISINTEGRATING · ASAFETIDA 3 [hp_X]/1, BISMUTH SUBNITRATE 6 [hp_X]/1, BRYONIA ALBA ROOT 6 [hp_X]/1, ACTIVATED CHARCOAL 6 [hp_X]/1, LYCOPODIUM CLAVATUM SPORE 6 [hp_X]/1, SODIUM CARBONATE 6 [hp_X]/1, STRYCHNOS NUX-VOMICA SEED 6 [hp_X]/1, VERATRUM ALBUM ROOT 6 [hp_X]/1
United StatesActive
Marketing holder: TRP Company
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- ASAFETIDA · 3 [hp_X]/1
- BISMUTH SUBNITRATE · 6 [hp_X]/1
- BRYONIA ALBA ROOT · 6 [hp_X]/1
- ACTIVATED CHARCOAL · 6 [hp_X]/1
- LYCOPODIUM CLAVATUM SPORE · 6 [hp_X]/1
- SODIUM CARBONATE · 6 [hp_X]/1
- STRYCHNOS NUX-VOMICA SEED · 6 [hp_X]/1
- VERATRUM ALBUM ROOT · 6 [hp_X]/1
Registration
- Registration number
- 17312-019
- Registration status
- Active
- Dispensing
- Over the counter
- Route
- ORAL
Sources
- product · openFDA NDC · 17312-019 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 17312-019 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 17312-019 · Verified 2026-10-09 · open in source
- ingredients.1 · openFDA NDC · 17312-019 · Verified 2026-10-09 · open in source
- ingredients.2 · openFDA NDC · 17312-019 · Verified 2026-10-09 · open in source
- ingredients.3 · openFDA NDC · 17312-019 · Verified 2026-10-09 · open in source
- ingredients.4 · openFDA NDC · 17312-019 · Verified 2026-10-09 · open in source
- ingredients.5 · openFDA NDC · 17312-019 · Verified 2026-10-09 · open in source
- ingredients.6 · openFDA NDC · 17312-019 · Verified 2026-10-09 · open in source
- ingredients.7 · openFDA NDC · 17312-019 · Verified 2026-10-09 · open in source